Overview

Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This research study will test to see if people who receive pregabalin after their spinal cord injury will develop less nerve damage pain than people who do not receive it.
Phase:
Phase 3
Details
Lead Sponsor:
Nova Scotia Health Authority
Treatments:
Pregabalin